NE MPJE flashcards
NE MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Federal vs. state law
- When federal and state pharmacy laws conflict, the stricter requirement generally controls; federal law sets a minimum standard, and Minnesota may impose additional requirements on top of it.
- Minnesota Pharmacy Practice Act
- Minn. Stat. ch. 151 governs pharmacist licensure, pharmacy registration, dispensing, and discipline in Minnesota; it is supplemented by Board rules in Minnesota Rules chs. 6800-6805.
- Record retention period
- Minnesota pharmacies must retain prescription and controlled substance records for at least two years and make them readily retrievable for Board or DEA inspection.
- Combat Methamphetamine Epidemic Act
- Federal law limiting daily and monthly sales of pseudoephedrine and related products, requiring photo ID, a written logbook, and storage behind the counter or in a locked cabinet.
- Pharmacist licensure requirements
- Graduation from an ACPE-accredited pharmacy program, passage of NAPLEX and MPJE, and completion of required internship hours under Minnesota Board rules.
- Pharmacy technician registration
- Minnesota requires pharmacy technicians to register with the Board and to work only under the direct supervision of a licensed pharmacist performing delegated tasks.
- Grounds for Board discipline
- Practicing beyond scope, unprofessional conduct, impairment, fraud in obtaining a license, and failure to maintain required records can lead to corrective action, suspension, or revocation.
- Pharmacy license is site-specific
- A Minnesota pharmacy license applies to a specific location and owner; changes in ownership, location, or pharmacist-in-charge must be reported to the Board within the rule-specified timeframe.
- Required prescription elements
- A valid prescription includes patient name, drug name, strength, dosage form, quantity, directions, prescriber name and signature, and date; missing elements require prescriber verification.
- Generic substitution rule
- A pharmacist may substitute a therapeutically equivalent generic unless the prescriber writes dispense as written or the patient refuses the substitution.
- Prescription label contents
- The label must show the pharmacy name and address, prescription number, date, patient name, directions, prescriber name, and any legally required cautionary statements.
- Refill authorization
- A prescription may be refilled only as authorized by the prescriber; a prescription with no refills requires prescriber contact before dispensing additional quantities.
- Schedule I characteristics
- Schedule I substances have high abuse potential and no accepted medical use in the United States; they cannot be prescribed and are limited to research with DEA registration.
- Schedule II refill prohibition
- Schedule II prescriptions may not be refilled; a pharmacist may dispense up to a 90-day supply only when the prescriber authorizes it under applicable state and federal rules.
- Schedule III-V refill limit
- Schedule III through V prescriptions may be refilled up to five times within six months of the date of issue unless the prescriber specifies a shorter period.
- DEA Form 106
- The form used to report theft or significant loss of controlled substances to the DEA; the pharmacy must also notify the state Board.
- Biennial inventory
- A complete count of all controlled substances in stock, conducted every two years on May 1 of odd-numbered years or on the date the pharmacy first dispenses controlled substances.
- Perpetual inventory
- An ongoing record of Schedule II receipts and disbursements that allows the pharmacy to reconcile the actual count with the expected count at any time.
- Minnesota PMP reporting
- Pharmacies must report dispensing data for controlled substances to the Minnesota Prescription Monitoring Program, and pharmacists must review PMP data before dispensing certain controlled substances.
- Quality assurance program
- A documented program for tracking medication errors and near misses, identifying causes, and implementing corrective actions, with records available to the Board.
- Counseling offer requirement
- A pharmacist must offer counseling for each new prescription covering drug name, purpose, directions, precautions, and interactions, unless the patient refuses.
- Counseling documentation
- The patient record should document the date, topics covered, and patient response or refusal of counseling, supporting the pharmacist's compliance with practice standards.
- HIPAA confidentiality
- Protected health information may be disclosed for treatment, payment, and health care operations without authorization, but other disclosures require patient authorization or a legal mandate.
- Therapeutic duplication check
- Before dispensing, the pharmacist must identify and resolve duplications, interactions, and contraindications, contacting the prescriber when a clinically significant problem is found.
- Child-resistant packaging
- The Poison Prevention Packaging Act requires child-resistant packaging for most prescription drugs, with exceptions for certain drugs and patient requests for non-child-resistant packaging.
- Drug Supply Chain Security Act
- Federal law requiring pharmacies to verify drug product authenticity and maintain transaction records to secure the pharmaceutical supply chain.
- REMS compliance
- The FDA may require a Risk Evaluation and Mitigation Strategy for drugs with serious safety concerns, and pharmacists must follow its dispensing and documentation requirements.
- MedWatch reporting
- Pharmacists report suspected serious adverse drug reactions and product problems to the FDA MedWatch program and notify the prescriber when appropriate.
- Prescriber DEA verification
- For controlled substance prescriptions, the pharmacist must verify the prescriber's DEA number and confirm the prescription was issued for a legitimate medical purpose.
- Red flag resolution
- A pharmacist who sees signs of diversion, forgery, or improper prescribing must resolve the concern with the prescriber or patient before dispensing the controlled substance.
- Transfer of prescriptions
- Refill prescriptions may be transferred between pharmacies, but Schedule II prescriptions cannot be transferred except as federal law permits; the transfer must be documented.
- Naloxone education
- Pharmacists must comply with federal and Minnesota requirements for opioid dispensing, including offering naloxone and educating patients on overdose prevention.